4.7 Letter

Successful treatment of severe COVID-19 with subcutaneous anakinra as a sole treatment

Journal

RHEUMATOLOGY
Volume 59, Issue 8, Pages 2171-2173

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keaa318

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available